Surgery with emicizumab prophylaxis for two paediatric patients with severe haemophilia A with inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Surgery with emicizumab prophylaxis for two paediatric patients with severe haemophilia A with inhibitors

Published:2021-04-13 Issue:7 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Lockhart Marguerite¹^ORCID,Tardy‐Poncet Brigitte²^ORCID,Montmartin Aurélie³,Noyel Pauline⁴,Thouvenin Sandrine¹,Berger Claire¹⁵^ORCID

Affiliation:

1. Hematology and Oncology Pediatric Unit Haemophilia CRC Hospital of Saint‐Etienne Saint‐Etienne France

2. INSERM CIC 1408 Laboratory of Hematology Saint‐Etienne France

3. Inserm U1059, Sainbiose Dysfonction Vasculaire et Hémostase Université de Lyon Saint‐Etienne France

4. Biology Laboratory University Hospital of Saint‐Etienne Saint‐Etienne France

5. EA SNA‐EPIS 4607 Université Jean Monnet Saint‐Etienne France

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29041

Reference30 articles.

1. The Hemophilias — From Royal Genes to Gene Therapy

2. The measurement and application of thrombin generation

3. Inhibitors in congenital coagulation disorders

4. The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia

5. Factor VIII therapy for hemophilia A: current and future issues

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern aspects of hemophilia A diagnosis;Pediatric Hematology/Oncology and Immunopathology;2024-04-18

2. Management of surgery in persons with hemophilia A receiving emicizumab prophylaxis: data from a national hemophilia treatment center;Research and Practice in Thrombosis and Haemostasis;2023-08

3. Management of children with hemophilia A on emicizumab who need surgery;Frontiers in Pediatrics;2023-04-04

4. Hemophilia A: Emicizumab monitoring and impact on coagulation testing;Advances in Clinical Chemistry;2023

5. Managing invasive procedures in haemophilia patients with limited resources, extended half‐life concentrates or non‐replacement therapies in 2022;Haemophilia;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3